Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about ONCY News Recent news which mentions ONCY News Oncolytics Biotech® Doses First Patient in Study of Pelareorep/FOLFIRINOX Combination Therapy in Pancreatic Cancer June 20, 2024 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep’s Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action May 24, 2024 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer May 09, 2024 Tickers ONC ONCY Tags Featured News ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA April 11, 2024 Tickers ONC ONCY Tags ONCY News Featured News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth March 06, 2024 Tickers BLRX CADL IMRX ONC Tags Featured News ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN March 05, 2024 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Cancer Immunotherapy Stocks – Tapping into Immune Systems for Next Generation Treatments February 15, 2024 Tickers ONC ONCY Tags ONCY News Featured News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort February 14, 2024 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors January 09, 2024 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024 January 04, 2024 Tickers ONC ONCY Tags Featured News ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Announces the Anal Cancer Cohort of the GOBLET Phase 1/2 Study of Pelareorep and Atezolizumab Has Met the Success Criteria for Efficacy November 09, 2023 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Achieves Success Criteria for Efficacy in the Third-Line Colorectal Cancer Cohort of the GOBLET Study October 23, 2023 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Presents Positive Updated Pancreatic Cancer Data from GOBLET Phase 1/2 Study at ESMO October 23, 2023 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® To Present Two Posters on the Pelareorep-Based GOBLET Study at ESMO 2023 October 16, 2023 Tickers ONC ONCY Tags ONCY News Featured News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS September 26, 2023 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech’s® Pelareorep Selected for Inclusion in Precision PromiseSM Pivotal Phase 3 Platform Trial June 22, 2023 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Announces Updated Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial that Show Pelareorep Driving Robust Increases in Progression-Free Survival and Confirmed Ov June 05, 2023 Tickers ONC ONCY Tags Featured News ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Announces Positive Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial Demonstrating Pelareorep Drives ≥50% Improvements in ORR and mPFS in an ASCO Annual Meetin May 26, 2023 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Reports First Quarter 2023 Financial Results and Operational Highlights May 05, 2023 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech’s® Chinese Development Partner Adlai Nortye Presents Interim Clinical Data Further Demonstrating the Anti-Cancer Activity of Pelareorep-Paclitaxel Combination Therapy in HR+/HER2- M December 08, 2022 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Receives FDA Fast Track Designation for the Treatment of Advanced/Metastatic Pancreatic Cancer December 01, 2022 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Presents Updated Clinical Data at SITC Annual Meeting Showing a 69% Objective Response Rate and Confirmed Complete Response in GOBLET Study’s Pancreatic Cancer Cohort November 10, 2022 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Reports Interim Results from Phase 1/2 GOBLET Study Showing a 70% Objective Response Rate in Pancreatic Cancer at the SITC Annual Meeting November 07, 2022 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 37th Annual Meeting October 05, 2022 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Achieves Success Criteria for Efficacy in the Pancreatic Cancer Cohort of GOBLET June 28, 2022 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® and SOLTI Present New Clinical Biomarker Data Demonstrating Pelareorep’s Potential to Improve the Prognosis of Breast Cancer Patients at the ESMO Breast Cancer Meeting May 04, 2022 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Announces Publication of Preclinical Data Demonstrating the Synergistic Anti-Cancer Activity of Pelareorep Combined with CAR T Cell Therapy in Solid Tumors in Science Translational April 14, 2022 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Partner Adlai Nortye Advances Chinese Bridging Trial of Pelareorep-Paclitaxel Combination Treatment in Breast Cancer to Final Dosing Cohort March 24, 2022 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Provides Positive Safety Update on the Pancreatic Cancer Cohort of its Multi-Indication Phase 1/2 Gastrointestinal Cancer Trial February 02, 2022 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Oncolytics Biotech® Partner Adlai Nortye Advances to the Second Dose Escalation Cohort of the Chinese Bridging Trial Evaluating Pelareorep-Paclitaxel Combination Treatment in Breast Cancer January 27, 2022 Tickers ONC ONCY Tags ONCY News From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.